Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 10:13:8473-8480.
doi: 10.2147/CMAR.S333721. eCollection 2021.

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

Affiliations

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

Tomoki Nakamura et al. Cancer Manag Res. .

Abstract

Purpose: Here, we investigated the oncological outcomes of lung metastasectomy and/or radiofrequency ablation (RFA) of 92 patients with soft tissue sarcoma (STS) at nine institutions.

Methods: The study cohort included 65 men and 27 women with a mean age of 59 years at the time of metastasis. The mean follow-up duration was 51 months. All patients underwent metastasectomy and/or RFA for lung metastasis.

Results: The mean maximum size of the initial lung metastasis was 14.6 mm. At the initial evaluation, 41 patients had a single metastasis, whereas 51 patients had multiple metastases. The mean number of metastasectomies and/or RFA was 2 per patient. A total of 70 patients underwent lung metastasectomy, whereas the other 13 underwent lung RFA. The remaining nine patients underwent both RFA and metastasectomy. The 5-year post-metastatic survival rate was 52%. The patients who underwent complete treatment for the initial metastasis had better post-metastatic survival rates than those who underwent incomplete treatment. A univariate analysis of all possible prognostic factors for complete treatment confirmed the predictive value of disease-free interval, metastasis at initial presentation, distribution, tumor size, and number of lung metastases. Of the 92 patients, 74 underwent complete treatment for initial metastasis; in these patients, univariate and multivariate analyses showed that a smaller tumor size and single-lung metastasis were prognostic factors for superior post-metastatic survival. The patients with a smaller (<11.5 mm) single metastasis had better post-metastasis survival. The 5-year post-metastatic survival rates were 89.9% for patients with a smaller (<11.5 mm) single metastasis versus 22.7% for patients with larger (>11.5 mm) and multiple metastases.

Discussion: We propose that complete treatment for lung metastasis in patients with STS may improve post-metastatic survival rates. Furthermore, tumor number and size are important variables for clinical decision-making.

Keywords: lung metastasis; metastasectomy; radiofrequency ablation; soft tissue sarcoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest for this study.

Figures

Figure 1
Figure 1
Kaplan–Meier curves showing the post-metastatic survival of 92 patients with soft tissue sarcoma after initial lung metastasis.
Figure 2
Figure 2
Kaplan–Meier curves showing post-metastatic survival according to the curability of the initial lung metastasis (A: complete treatment, B: incomplete treatment).
Figure 3
Figure 3
Kaplan–Meier curves showing the post-metastatic survival of 72 patients according to the curability of the initial lung metastasis (A: single and smaller [<11.5 mm]; B: multiple and smaller [<11.5 mm], C; single and larger [>11.5 mm], D; multiple and larger [>11.5 mm]).

Similar articles

Cited by

References

    1. Bourcier K, Le Cense A, Tselikas L, et al. Basic knowledge in soft tissue sarcoma. Cardiovasc Intervent Radiol. 2019;42(9):1255–1261. doi:10.1007/s00270-019-02259-w - DOI - PubMed
    1. Stamenovic D, Hohenberger P, Roessner E. Pulmonary metastasectomy in soft tissue sarcomas: a systematic review. J Thorac Dis. 2021;13(4):2649–2660. doi:10.21037/jtd-2019-pm-13 - DOI - PMC - PubMed
    1. Nakamura T, Matsumine A, Takao M, et al. Impact of tumor volume doubling time on post-metastatic survival in bone and soft- tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung. Onco Targets Ther. 2017;10:559–564. doi:10.2147/OTT.S121562 - DOI - PMC - PubMed
    1. Marulli G, Mammana M, Comacchio G, Rea F. Survival and prognostic factors following pulmonary metastasectomy for sarcoma. J Thorac Dis. 2017;9(Suppl 12):S1305–S1315. doi:10.21037/jtd.2017.03.177 - DOI - PMC - PubMed
    1. Nakamura T, Matsumine A, Yamakado K, et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas. Cancer. 2009;115(16):3774–3781. doi:10.1002/cncr.24420 - DOI - PubMed